Trials / Completed
CompletedNCT00942760
Protocol to Distinguish Tumor Recurrence From Treatment-Related Necrosis in Patients With High Grade Gliomas
DMS-0901: Multimodal Magnetic Resonance Protocol to Distinguish Tumor Recurrence From Treatment-Related Necrosis in Patients With High Grade Gliomas
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 12 (actual)
- Sponsor
- Dartmouth-Hitchcock Medical Center · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Brain imaging tests are routinely used to detect the presence of a brain tumor or to evaluate the response to treatment. Sometimes the images obtained are not specific and the only way to establish a diagnosis is by obtaining a tissue sample. The hypotheses of the study is to determine if multimodal MR technique will provide tissue signatures that differentiate between tumor progression and treatment related necrosis in high grade glioma patients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | 3T MRI | The introduction of the 3T scanners provides a potential opportunity to improve the quality of imaging in neuro-oncology. |
Timeline
- Start date
- 2009-04-01
- Primary completion
- 2011-03-01
- Completion
- 2011-04-01
- First posted
- 2009-07-21
- Last updated
- 2013-05-08
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00942760. Inclusion in this directory is not an endorsement.